The purpose is to investigate whether HIV and HIV medication can affect certain areas of
brain function. This study will look at possible changes in brain function including memory,
concentration and thought processes to see if there are any differences between the two doses
of efavirenz used in the Encore1 study and also the level of efavirenz in the blood
Phase:
Phase 3
Details
Lead Sponsor:
Kirby Institute
Collaborator:
The HIV Netherlands Australia Thailand Research Collaboration